Prevention of breast cancer

被引：7

作者：

Carolin, KA ^{[1
]}

Pass, HA ^{[1
]}

机构：

[1] Univ Michigan, Ann Arbor, MI 48109 USA

来源：

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2000年 / 33卷 / 03期

关键词：

D O I：

10.1016/S1040-8428(99)00076-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

With the advent of screening and the increased incidence of breast cancer, concern for the prevention of breast cancer has become forefront in today's society. Determining individual risk is the key to prescribing prevention. Prevention of breast cancer is still under clinical investigation with only one drug, tamoxifen, showing benefit in high risk patients. This paper reviews the possible sites for prevention of neoplastic transformation via biomarkers in a breast cell as well as the investigational drugs and their potential use in the chemoprevention of breast cancer. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.

引用

页码：221 / 238

页数：18

共 171 条

[1]

The Bcl-2 protein family: Arbiters of cell survival [J].